Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 3

Clinical and pathological predictors of persistence after conization for high-grade squamous intraepithelial lesions: a single-center study

Görkem Aktaş(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-8402-5536
Belma Gözde Özdemir(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-7025-4087
Mete Bertizlioğlu(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-1557-5774
Mercan Aslan(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0009-0003-6409-152X
Ahmet Bilgi(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-8682-1739
Çetin Çelik(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-6165-5092
Pages
—
Publication Date
2026-06-25
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Positive surgical margins and HPV positivity during follow-up are significantly associated with persistence after excisional HSIL treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: High-grade squamous intraepithelial lesion (HSIL) is among the important precursor lesions of cervical cancer, and progression to invasive cancer can be largely prevented with early diagnosis and appropriate treatment.
📊
Key Findings & Data:However, the persistence or recurrence of the lesion after excisional treatment in some patients remains a clinically significant problem.
💡
Conclusion & Impact:Conclusion: Positive surgical margins and HPV positivity during follow-up are significantly associated with persistence after excisional HSIL treatment.
🔬Design:Review & Systematic Survey
📍Scope:2024 Verileri
⚙️Variables:HSIL · cervical intraepithelial neoplasia · persistence

Abstract

Aims: High-grade squamous intraepithelial lesion (HSIL) is among the important precursor lesions of cervical cancer, and progression to invasive cancer can be largely prevented with early diagnosis and appropriate treatment. Excisional procedures, especially loop electrosurgical excision procedure (LEEP), are commonly used to treat HSIL. However, the persistence or recurrence of the lesion after excisional treatment in some patients remains a clinically significant problem. Surgical margin status, human papillomavirus (HPV) infection, and various clinical factors are thought to play a role in the development of persistence. Therefore, identifying the factors that affect persistence after excisional treatment is important for optimizing follow-up and management strategies for patients. The aim of this study is to evaluate demographic, clinical, and pathological factors associated with post-treatment persistence in patients diagnosed with HSIL and treated with conization. Methods: This retrospective study was conducted at a tertiary referral center and included patients diagnosed with HSIL and treated with conization between 2024 and 2025. A total of 69 patients with histopathologically confirmed HSIL were included in the study. Persistence was observed in 46 patients (66.7%), while no persistence was observed in 23 patients (33.3%). Demographic characteristics, clinical findings, and pathological data of the patients were retrospectively reviewed from their patient files. Data collected included age, surgical margin status, length of the removed specimen, and HPV status during follow-up. Patients were divided into two groups based on whether persistence developed during follow-up. Correlation analyses and logistic regression models were used to evaluate factors associated with persistence. Results: No significant differences were found between patients with and without persistence in terms of age, menopausal status, marital status, and smoking (p>0.05). However, positive surgical margins were significantly associated with persistence (p=0.003). In the evaluation of clinicopathological factors, the persistence rate was significantly higher in patients with positive high-risk HPV types (e.g., HPV 16, HPV 31) during follow-up (p=0.002). In logistic regression analysis, positive surgical margins and positive HPV status at follow-up were significant predictors of persistence. Conclusion: Positive surgical margins and HPV positivity during follow-up are significantly associated with persistence after excisional HSIL treatment.

🔖

Cite This Article

Aktaş, G., Özdemir, B. G., Bertizlioğlu, M., Aslan, M., Bilgi, A., Çelik, Ç. (2026). Clinical and pathological predictors of persistence after conization for high-grade squamous intraepithelial lesions: a single-center study. Journal of Medicine and Palliative Care, Volume: 7 Issue: 3. https://doi.org/10.47582/jompac.1911122

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169-182. doi:10.1016/S0140-6736(18)32470-X
  2. Kyrgiou M, Athanasiou A, Paraskevaidi M, et al. The role of human papillomavirus testing in the follow-up of women treated for CIN: a systematic review and meta-analysis. Lancet Oncol. 2020;21(3):e135-e145. doi:10.1016/S1470-2045(19)30759-0
  3. Kang WD, Kim SM, Kim YH, et al. Human papillomavirus persistence and recurrence after treatment of cervical intraepithelial neoplasia. Gynecol Oncol. 2021;160(2):457-463.
  4. Paraskevaidis E, Arbyn M, Sotiriadis A, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev. 2004;30(2):205-211. doi:10. 1016/j.ctrv.2003.07.008
  5. Arbyn M, Redman CWE, Verdoodt F, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18(12):1665-1679. doi:10.1016/S1470-2045(17)30700-3
  6. Leguevaque P, Motton S, Decharme A, Soulé-Tholy M, Escourrou G, Hoff J. Predictors of recurrence in high-grade cervical lesions and a plan of management. Eur J Surg Oncol. 2010;36(11):1073-1079. doi:10.1016/j.ejso.2010.08.135
  7. Zhu M, He Y, Baak JP, et al. Factors that influence persistence or recurrence of high-grade squamous intraepithelial lesion with positive margins after the loop electrosurgical excision procedure: a retrospective study. BMC Cancer. 2015;15(1):744. doi:10.1186/s12885-015-1748-1
  8. Pangarkar MA. The Bethesda System for reporting cervical cytology. Cytojournal. 2022;19:28. doi:10.25259/CMAS_03_07_2021
  9. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2): 102-131. doi:10.1097/LGT.0000000000000525
  10. Kang WD, Choi HS, Kim SM. Is human papillomavirus persistence a prognostic factor for recurrence after LEEP in high-grade cervical intraepithelial neoplasia? Gynecol Oncol. 2011;120(3):366-370.
  11. Baser E, Ozgu E, Erkilinc S, Togrul C, Caglar M, Gungor T. Risk factors for human papillomavirus persistence among women undergoing cold-knife conization for treatment of high-grade cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2014;125(3):275-278. doi:10.1016/j.ijgo. 2013.12.012
  12. Brockmeyer AD, Wright JD, Gao F, Powell MA. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. Am J Obstet Gynecol. 2005;192(5):1379-1381. doi:10.1016/j.ajog.2004.12.044
  13. Elfström KM, Smelov V, Johansson ALV, et al. Long term duration of protective effect for HPV-negative women: follow-up of primary HPV screening randomised controlled trial. BMJ. 2014;348:g130. doi:10.1136/bmj.g130
  14. Loopik DL, IntHout J, Ebisch RMF, Melchers WJG, Massuger LFAG, Bekkers RLM. The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis. J Low Genit Tract Dis. 2021;25(3):221-231. doi:10.1097/LGT.0000000000000604
  15. Nam K, Chung S, Kim J, Jeon S, Bae D. Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol. 2009;20(2):91-95. doi:10.3802/jgo.2009.20.2.91
  16. Kang WD, Ju UC, Kim SM. Human papillomavirus genotyping for predicting disease progression in women with cervical lesions. Int J Gynecol Cancer. 2024;34(1):12-18. doi:10.1136/ijgc-2023-004902
  17. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991-998. doi:10.1016/S0140-6736(05)67069-9
  18. Arbyn M, Sasieni P, Meijer CJLM, Clavel C, Koliopoulos G, Dillner J. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24(Suppl 3):S78-89. doi:10.1016/j.vaccine.2006.05.117